CohortLSE:CHRT -1.00%93 EBITDA Margin % is 11.43% as of Oct. 2025, which is 19% below its 10-year median of 14.08. GuruFocus rates LSE:CHRT with a GF Score™ of 93/100 and a GF Value™ of £10.77 (Fairly Valued). The stock has 4 warning signs investors should review. Among 347 Aerospace & Defense companies, Cohort ranks better than 55.91% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cohort's EBITDA for the
six
months ended in Oct. 2025 was £14.7 Mil. Cohort's Revenue for the
six
months ended in Oct. 2025 was £128.8 Mil. Therefore, Cohort's EBITDA margin for the quarter that ended in Oct. 2025 was 11.43%.
Cohort (LSE:CHRT) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Cohort EBITDA Margin % Related Terms
Cohort EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Cohort's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:CHRT vs GE, RTX, BA: EBITDA Margin % Comparison
For the Aerospace & Defense subindustry, Cohort's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cohort EBITDA Margin % vs Aerospace & Defense Industry
For the Aerospace & Defense industry and Industrials sector, Cohort's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Cohort's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cohort (LSE:CHRT) has a EBITDA Margin % of 11.43% as of Oct. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Cohort and its competitors. This is 19% below median its historical median of 14.08. Over the past decade, Cohort's EBITDA Margin % has ranged from 11.35 to 15.83. According to the industry distribution chart, Cohort ranks #153 out of 347 companies in the Aerospace & Defense industry, placing it in the top 44.1%.
Is Cohort's EBITDA Margin % too high?
Cohort's current EBITDA Margin % of 11.43% is 19% below median its 10-year median of 14.08. Over the past 10 years, this metric has ranged from a low of 11.35 to a high of 15.83. The Aerospace & Defense industry median EBITDA Margin % is 11.96. Cohort's value of 11.43% is 4.4% below this industry median. Based on the distribution chart, Cohort ranks #153 out of 347 companies in the Aerospace & Defense industry, which is above the industry midpoint. Overall, Cohort has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cohort's EBITDA Margin % compare to GE and RTX?
According to the Aerospace & Defense industry distribution chart, Cohort ranks #153 out of 347 companies for EBITDA Margin %. This puts Cohort in the upper half of its industry. The industry median EBITDA Margin % is 11.96. Cohort's value of 11.43% is 4.4% below this benchmark. Historically, Cohort's own EBITDA Margin % has ranged from 11.35 to 15.83 over the past decade. While the company's 10-year median is 14.08 vs. the industry median of 11.96, Cohort has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Aerospace & Defense company?
The median EBITDA Margin % among Aerospace & Defense companies is 11.96, based on 347 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cohort's current EBITDA Margin % of 11.43% is 4.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Cohort and its competitors. For the Aerospace & Defense industry, the median EBITDA Margin % is 11.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cohort's current EBITDA Margin % is 11.43%, which is 19% below median its own 10-year median of 14.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cohort stock overvalued right now?
Based on GuruFocus' analysis, Cohort (LSE:CHRT) is currently considered Fairly Valued. The stock's GF Value™ is £10.77, compared to a current price of £11.86 — trading 10.1% above its estimated fair value. The current EBITDA Margin % is 11.43%, which is 19% below median its 10-year median of 14.08 and 4.4% below the Aerospace & Defense industry median of 11.96. Cohort's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Cohort (LSE:CHRT), the current EBITDA Margin % is 11.43% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cohort (LSE:CHRT) Overvalued in 2026?
Based on GuruFocus' analysis, Cohort stock appears to be overvalued.
The current stock price of £11.86 is trading 10.1% above its estimated GF Value™ of £10.77.
GuruFocus considers Cohort to be Fairly Valued.
Key valuation signals for LSE:CHRT:
EBITDA Margin %: 11.43% (19% below median its 10-year median of 14.08)
GF Value™: £10.77 vs. price of £11.86 (10.1% above fair value)
Industry Position: 4.4% below the Aerospace & Defense median (#153 of 347)
No single metric tells the full story. See the LSE:CHRT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cohort PLC is the parent company of seven businesses that provide services and products for customers in the defence, security, and related sectors in the United Kingdom and international markets. Its businesses include Chess, EID, ELAC Sonar, EM Solutions, MASS, MCL and SEA. The company has operations in UK, Portugal, Australia and Canada.
93GF Score
Get the complete analysis for LSE:CHRT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CHRT has been successfully added to your 
